Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
10x Genomics Community
NasdaqGS:TXG Community
1
Narratives
written by author
0
Comments
on narratives written by author
17
Fair Values set
on narratives written by author
Create a narrative
10x Genomics
Popular
Undervalued
Overvalued
Community Investing Ideas
10x Genomics
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Chan Zuckerberg Initiative Partnership Will Drive Future Demand
Key Takeaways Strategic introduction of lower-priced products and sales reorganization are poised to drive volume growth and enhance market share in biopharma and academia. Expansion in biopharma and partnership initiatives like the Billion Cells Project present significant opportunities for long-term revenue and demand growth.
View narrative
US$15.42
FV
48.4% undervalued
intrinsic discount
5.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
TXG
TXG
10x Genomics
Your Fair Value
US$
Current Price
US$7.96
50.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-543m
816m
2015
2018
2021
2024
2025
2027
2030
Revenue US$816.4m
Earnings US$100.9m
Advanced
Set Fair Value